JP6618660B2 - 誤嚥性肺炎、肺化膿症又は肺膿瘍の治療剤 - Google Patents
誤嚥性肺炎、肺化膿症又は肺膿瘍の治療剤 Download PDFInfo
- Publication number
- JP6618660B2 JP6618660B2 JP2019525551A JP2019525551A JP6618660B2 JP 6618660 B2 JP6618660 B2 JP 6618660B2 JP 2019525551 A JP2019525551 A JP 2019525551A JP 2019525551 A JP2019525551 A JP 2019525551A JP 6618660 B2 JP6618660 B2 JP 6618660B2
- Authority
- JP
- Japan
- Prior art keywords
- genus
- bacteria belonging
- bacteria
- therapeutic agent
- abscess
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762520961P | 2017-06-16 | 2017-06-16 | |
| US62/520,961 | 2017-06-16 | ||
| JP2018068159 | 2018-03-30 | ||
| JP2018068159 | 2018-03-30 | ||
| PCT/JP2018/022846 WO2018230686A1 (ja) | 2017-06-16 | 2018-06-15 | 誤嚥性肺炎、肺化膿症又は肺膿瘍の治療剤 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019200166A Division JP6671532B2 (ja) | 2017-06-16 | 2019-11-01 | 誤嚥性肺炎、肺化膿症又は肺膿瘍の治療剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP6618660B2 true JP6618660B2 (ja) | 2019-12-11 |
| JPWO2018230686A1 JPWO2018230686A1 (ja) | 2019-12-12 |
Family
ID=66213244
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019525551A Active JP6618660B2 (ja) | 2017-06-16 | 2018-06-15 | 誤嚥性肺炎、肺化膿症又は肺膿瘍の治療剤 |
| JP2019200166A Active JP6671532B2 (ja) | 2017-06-16 | 2019-11-01 | 誤嚥性肺炎、肺化膿症又は肺膿瘍の治療剤 |
| JP2020036036A Active JP7098671B2 (ja) | 2017-06-16 | 2020-03-03 | 誤嚥性肺炎、肺化膿症又は肺膿瘍の治療剤 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019200166A Active JP6671532B2 (ja) | 2017-06-16 | 2019-11-01 | 誤嚥性肺炎、肺化膿症又は肺膿瘍の治療剤 |
| JP2020036036A Active JP7098671B2 (ja) | 2017-06-16 | 2020-03-03 | 誤嚥性肺炎、肺化膿症又は肺膿瘍の治療剤 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20210137913A1 (https=) |
| EP (1) | EP3639826A4 (https=) |
| JP (3) | JP6618660B2 (https=) |
| KR (1) | KR20200016960A (https=) |
| CN (1) | CN110891571A (https=) |
| AU (1) | AU2018283234A1 (https=) |
| BR (1) | BR112019025960A2 (https=) |
| CA (1) | CA3067188A1 (https=) |
| CL (1) | CL2019003630A1 (https=) |
| IL (1) | IL270831A (https=) |
| MX (1) | MX2019014931A (https=) |
| PH (1) | PH12019502835A1 (https=) |
| SG (1) | SG11201911826VA (https=) |
| TW (1) | TWI818910B (https=) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19962470A1 (de) * | 1999-12-22 | 2001-07-12 | Schulz Hans Herrmann | Verwendung von Chemotherapeutika |
| CN100410249C (zh) | 2003-09-10 | 2008-08-13 | 杏林制药株式会社 | 7-(4-取代-3-环丙基氨基甲基-1-吡咯烷基)喹诺酮羧酸衍生物 |
| SA112330992B1 (ar) | 2011-11-10 | 2015-09-13 | كيورين فارماسوتيكال كو.، ليمتد | صورة متبلرة من 7-{(s4، s3)-3-[(سيكلو بروبيل أمينو) ميثيل]-4-فلورو بيروليدين-1-يل}-6-فلورو-1-(2-فلورو إيثيل)- 8-ميثوكسي-4-أوكسو-1، 4-داي هيدرو كينولين-3- حمض كربوكسيلي |
| WO2016148066A1 (ja) * | 2015-03-13 | 2016-09-22 | 杏林製薬株式会社 | 呼吸器感染症治療剤 |
| EP3305294A4 (en) * | 2015-06-02 | 2019-02-20 | Kyorin Pharmaceutical Co., Ltd. | AQUEOUS MEDICINE |
-
2018
- 2018-06-15 BR BR112019025960-0A patent/BR112019025960A2/pt not_active IP Right Cessation
- 2018-06-15 AU AU2018283234A patent/AU2018283234A1/en not_active Abandoned
- 2018-06-15 TW TW107120774A patent/TWI818910B/zh active
- 2018-06-15 JP JP2019525551A patent/JP6618660B2/ja active Active
- 2018-06-15 KR KR1020207000644A patent/KR20200016960A/ko not_active Ceased
- 2018-06-15 SG SG11201911826VA patent/SG11201911826VA/en unknown
- 2018-06-15 EP EP18818391.7A patent/EP3639826A4/en not_active Withdrawn
- 2018-06-15 CA CA3067188A patent/CA3067188A1/en not_active Abandoned
- 2018-06-15 MX MX2019014931A patent/MX2019014931A/es unknown
- 2018-06-15 CN CN201880039674.9A patent/CN110891571A/zh active Pending
- 2018-06-15 US US16/620,630 patent/US20210137913A1/en not_active Abandoned
-
2019
- 2019-11-01 JP JP2019200166A patent/JP6671532B2/ja active Active
- 2019-11-21 IL IL270831A patent/IL270831A/en unknown
- 2019-12-11 CL CL2019003630A patent/CL2019003630A1/es unknown
- 2019-12-16 PH PH12019502835A patent/PH12019502835A1/en unknown
-
2020
- 2020-03-03 JP JP2020036036A patent/JP7098671B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR20200016960A (ko) | 2020-02-17 |
| TW201906607A (zh) | 2019-02-16 |
| IL270831A (en) | 2020-01-30 |
| PH12019502835A1 (en) | 2020-10-05 |
| JP6671532B2 (ja) | 2020-03-25 |
| JP2020079330A (ja) | 2020-05-28 |
| AU2018283234A1 (en) | 2019-12-12 |
| MX2019014931A (es) | 2020-02-13 |
| US20210137913A1 (en) | 2021-05-13 |
| CL2019003630A1 (es) | 2020-07-10 |
| JP2020015769A (ja) | 2020-01-30 |
| EP3639826A4 (en) | 2021-03-03 |
| CN110891571A (zh) | 2020-03-17 |
| JPWO2018230686A1 (ja) | 2019-12-12 |
| EP3639826A1 (en) | 2020-04-22 |
| TWI818910B (zh) | 2023-10-21 |
| JP7098671B2 (ja) | 2022-07-11 |
| CA3067188A1 (en) | 2018-12-20 |
| SG11201911826VA (en) | 2020-01-30 |
| BR112019025960A2 (pt) | 2020-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20210228589A1 (en) | Use of aerosolized levofloxacin for treating cystic fibrosis | |
| Wise | Maximizing efficacy and reducing the emergence of resistance | |
| JP6618660B2 (ja) | 誤嚥性肺炎、肺化膿症又は肺膿瘍の治療剤 | |
| JP6077725B1 (ja) | 呼吸器感染症治療剤 | |
| WO2018230686A1 (ja) | 誤嚥性肺炎、肺化膿症又は肺膿瘍の治療剤 | |
| HK40098387A (zh) | 吸入性肺炎、肺化脓或肺脓肿的治疗剂 | |
| HK40026671A (en) | Therapeutic agent for aspiration pneumonia, lung suppuration, or lung abscess | |
| HK40067557B (zh) | 呼吸器官感染治疗剂 | |
| AU2015275224C1 (en) | Use of aerosolized levofloxacin for treating cystic fibrosis | |
| Shetty et al. | Randomised, single blinded, controlled, prospective study comparing ketamine, lignocaine and chlorhexidine gargle in prevention of post-operative sore throat | |
| HK1168786B (en) | Use of aerosolized levofloxacin for treating cystic fibrosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20191025 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20191025 |
|
| A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20191025 |
|
| A975 | Report on accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A971005 Effective date: 20191106 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20191112 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20191112 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6618660 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R153 | Grant of patent term extension |
Free format text: JAPANESE INTERMEDIATE CODE: R153 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |